HbO2 Therapeutics

Hemoglobin Oxygen Therapeutics LLC is a leader in the development of human and veterinary hemoglobin-based oxygen carriers (HBOCs), which enhance the oxygen-carrying capacity of blood when administered intravenously. The company has two core products: Hemopure® (HBOC-201) for human use and Oxyglobin® for veterinary applications.